Showing 1 - 20 results of 524 for search '"L-DOPA"', query time: 0.16s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Plasma concentrations of L-dopa and 3-methoxydopa and improvement in clinical ratings and motor performance in patients with Parkinsonism treated with L-dopa alone or in combination with amantadine. by Pilling, J, Baker, J, Iversen, L, Iversen, S, Robbins, T

    Published 1975
    “…Six patients with idiopathic Parkinsonism were treated with a combination of amantadine and L-dopa and after 12 to 24 weeks amantadine was replaced by placebo for a six week period in a double-blind trial. …”
    Journal article
  5. 5

    Effects of hydrogen gas inhalation on L-DOPA-induced dyskinesia by Glauce C. Nascimento, Bruna M. Santos, João F. Pedrazzi, Danyelle Silva-Amaral, Mariza Bortolanza, Grant T. Harris, Elaine Del Bel, Luiz G.S. Branco

    Published 2023-07-01
    “…L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesia is a side effect of Parkinson's disease treatment and it is characterized by atypical involuntary movements. …”
    Get full text
    Article
  6. 6

    Propranolol Relieves L-Dopa-Induced Dyskinesia in Parkinsonian Mice by Ziqing Shi, Ian J. Bamford, Jonathan W. McKinley, Suma Priya Sudarsana Devi, Annie Vahedipour, Nigel S. Bamford

    Published 2020-11-01
    “…Background: Parkinsonism is caused by dopamine (DA) insufficiency and results in a hypokinetic movement disorder. Treatment with L-Dopa can restore DA availability and improve motor function, but patients can develop L-Dopa-induced dyskinesia (LID), a secondary hyperkinetic movement disorder. …”
    Get full text
    Article
  7. 7

    Kinetic evaluation of L-Dopa loaded WGA-grafted nanoparticles by Sema Arisoy, Tansel Comoglu

    Published 2020-06-01
    “…In this study wheat germ agglutinin (WGA) conjugated, L-Dopa loaded, poly lactic-co-glycolic acid (PLGA) nanoparticles were analyzed for determining the release pattern of L-Dopa. …”
    Get full text
    Article
  8. 8
  9. 9
  10. 10

    L-DOPA enhances neural direction signals in younger and older adults by Christoph Koch, Christian Baeuchl, Franka Glöckner, Philipp Riedel, Johannes Petzold, Michael N. Smolka, Shu-Chen Li, Nicolas W. Schuck

    Published 2022-12-01
    “…We studied the effect of L-DOPA, a dopamine precursor, on fMRI activation patterns that encode spatial walking directions that have previously been shown to lose specificity with age. …”
    Get full text
    Article
  11. 11

    An Overview of Methods for L-Dopa Extraction and Analytical Determination in Plant Matrices by Carmen Tesoro, Filomena Lelario, Rosanna Ciriello, Giuliana Bianco, Angela Di Capua, Maria Assunta Acquavia

    Published 2022-08-01
    “…L-dopa is a precursor of dopamine used as the most effective symptomatic drug treatment for Parkinson’s disease. …”
    Get full text
    Article
  12. 12

    Nigrostriatal damage is required for induction of dyskinesias by L-DOPA in squirrel monkeys. by Boyce, S, Rupniak, N, Steventon, M, Iversen, S

    Published 1990
    “…These findings provide further evidence that nigrostriatal damage is essential for the genesis of L-DOPA-induced dyskinesias.…”
    Journal article
  13. 13

    Characterisation of dyskinesias induced by L-dopa in MPTP-treated squirrel monkeys. by Boyce, S, Rupniak, N, Steventon, M, Iversen, S

    Published 1990
    “…Intermittent treatment with L-dopa over a 2-year period induced abnormal involuntary movements in MPTP-treated squirrel monkeys. …”
    Journal article
  14. 14
  15. 15

    Structural, Conformational and Spectroscopic Investigations of a Biologically Active Compound: L-Dopa by Rohit Kumar Yadav, Ram Anjore Yadav, Irena Kostova

    Published 2023-12-01
    “…Structural, conformational and spectroscopic investigations of the L-dopa molecule were made at the b3lyp/6-311++g** level using the Gaussian 09 software. …”
    Get full text
    Article
  16. 16

    Pyrylium based derivatization imaging mass spectrometer revealed the localization of L-DOPA. by Shu Taira, Akari Ikeda, Yuki Sugiura, Hitomi Shikano, Shoko Kobayashi, Tsutomu Terauchi, Jun Yokoyama

    Published 2022-01-01
    “…Simultaneous imaging of l-dihydroxyphenylalanine (l-DOPA), dopamine (DA) and norepinephrine (NE) in the catecholamine metabolic pathway is particularly useful because l-DOPA is a neurophysiologically important metabolic intermediate. …”
    Get full text
    Article
  17. 17
  18. 18
  19. 19

    Fear extinction rescuing effects of dopamine and L-DOPA in the ventromedial prefrontal cortex by Simone B. Sartori, Thomas M. V. Keil, Kai K. Kummer, Conor P. Murphy, Ozge Gunduz-Cinar, Michaela Kress, Karl Ebner, Andrew Holmes, Nicolas Singewald

    Published 2024-01-01
    “…Systemic L-DOPA enabled extinction learning and promoted extinction retention at one but not ten days after training. …”
    Get full text
    Article
  20. 20

    l‐Dopa responsiveness is associated with distinctive connectivity patterns in advanced Parkinson's disease by Akram, H, Wu, C, Hyam, J, Foltynie, T, Limousin, P, De Vita, E, Yousry, T, Jahanshahi, M, Hariz, M, Behrens, T, Ashburner, J, Zrinzo, L

    Published 2017
    “…CONCLUSIONS:Our findings show characteristic basal ganglia resting-state functional connectivity patterns associated with different degrees of l-dopa responsiveness in patients with advanced Parkinson's disease. l-Dopa exerts a graduated influence on remapping connectivity in distinct motor control networks, potentially explaining some of the variance in treatment response. © 2017 International Parkinson and Movement Disorder Society.…”
    Journal article